Business Description
Sakar Healthcare Ltd
ISIN : INE732S01012
Total Employee Number:
342Compare
Compare
Traded in other countries / regions
SAKAR.India IPO Date
2016-10-14Description
Sakar Healthcare Ltd is engaged in manufacturing Pharmaceutical products providing Liquid Orals, Cephalosporin Tablet, Capsule, Dry Powder Syrup, Dry Powder Injections, Liquid Injectables (SVP) in Ampoules and Vials & Lyophilized Injections. The company offers its products to Sri Lanka, the Philippines, Vietnam, Cambodia, Sudan, Myanmar, Mauritius, Costa Rica, Panama, El Salvador and Paraguay.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.01 | |||||
Equity-to-Asset | 0.68 | |||||
Debt-to-Equity | 0.17 | |||||
Debt-to-EBITDA | 0.78 | |||||
Interest Coverage | 5.77 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 7.86 | |||||
Beneish M-Score | -1.14 | |||||
WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 16.4 | |||||
3-Year EBITDA Growth Rate | 16.8 | |||||
3-Year EPS without NRI Growth Rate | 25.6 | |||||
3-Year Book Growth Rate | 17 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 81.01 | |||||
9-Day RSI | 71.23 | |||||
14-Day RSI | 66.45 | |||||
3-1 Month Momentum % | 33.22 | |||||
6-1 Month Momentum % | 103.68 | |||||
12-1 Month Momentum % | 140.93 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.28 | |||||
Quick Ratio | 0.64 | |||||
Days Inventory | 156.09 | |||||
Days Sales Outstanding | 54.51 | |||||
Days Payable | 107.22 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -5.3 | |||||
Shareholder Yield % | 0.44 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 51.03 | |||||
Operating Margin % | 18 | |||||
Net Margin % | 12.11 | |||||
EBITDA Margin % | 28.27 | |||||
FCF Margin % | 8.3 | |||||
OCF Margin % | 19.57 | |||||
ROE % | 10.01 | |||||
ROA % | 6.8 | |||||
ROIC % | 8.51 | |||||
3-Year ROIIC % | 18.17 | |||||
ROC (Joel Greenblatt) % | 12.7 | |||||
ROCE % | 13.17 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 66.07 | |||||
Forward PE Ratio | 38.9 | |||||
PE Ratio without NRI | 66.07 | |||||
Shiller PE Ratio | 8.63 | |||||
PS Ratio | 7.99 | |||||
PB Ratio | 6.2 | |||||
Price-to-Tangible-Book | 6.34 | |||||
Price-to-Free-Cash-Flow | 96.27 | |||||
Price-to-Operating-Cash-Flow | 40.86 | |||||
EV-to-EBIT | 42.86 | |||||
EV-to-EBITDA | 28.66 | |||||
EV-to-Revenue | 8.11 | |||||
EV-to-FCF | 89.2 | |||||
Price-to-GF-Value | 1.67 | |||||
Price-to-Projected-FCF | 16.1 | |||||
Price-to-Peter-Lynch-Fair-Value | 5.44 | |||||
Price-to-Graham-Number | 4.31 | |||||
Earnings Yield (Greenblatt) % | 2.33 | |||||
FCF Yield % | 1.06 | |||||
Forward Rate of Return (Yacktman) % | -85.31 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Sakar Healthcare Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 2,517.36 | ||
| EPS (TTM) (₹) | 13.69 | ||
| Beta | 0.317 | ||
| 3-Year Sharpe Ratio | 0.96 | ||
| 3-Year Sortino Ratio | 2.48 | ||
| Volatility % | 41.29 | ||
| 14-Day RSI | 66.45 | ||
| 14-Day ATR (₹) | 48.853718 | ||
| 20-Day SMA (₹) | 825.3925 | ||
| 12-1 Month Momentum % | 140.93 | ||
| 52-Week Range (₹) | 311 - 944.4 | ||
| Shares Outstanding (Mil) | 21.95 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Sakar Healthcare Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Sakar Healthcare Ltd Stock Events
| Event | Date | Price (₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
Sakar Healthcare Ltd Frequently Asked Questions
What is Sakar Healthcare Ltd(NSE:SAKAR)'s stock price today?
The current price of NSE:SAKAR is ₹904.45. The 52 week high of NSE:SAKAR is ₹944.40 and 52 week low is ₹311.00.
When is next earnings date of Sakar Healthcare Ltd(NSE:SAKAR)?
The next earnings date of Sakar Healthcare Ltd(NSE:SAKAR) is .
Does Sakar Healthcare Ltd(NSE:SAKAR) pay dividends? If so, how much?
Sakar Healthcare Ltd(NSE:SAKAR) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Sakar Healthcare Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers